Sort
48,018 grants matching “immunotherapy”
Immunotherapy for acute lung injury secondary to influenza
$436,772Paul R Knight · State University Of New York At Buffalo · R01 · FY2023 · HL
Characterizing and Targeting the Novel IL-15- AKT-XBP1s Pathway in NK Cells
$436,772Jianhua Yu · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
Using dietary glutamine supplementation for melanoma prevention and targeted therapy
$436,727Mei Kong · University Of California-Irvine · R01 · FY2021 · CA
Immunoregulatory networks and HIV pathogenesis
$436,700Daniel E Kaufmann · Massachusetts General Hospital · R01 · FY2010 · HL
Immunoregulatory networks and HIV pathogenesis
$436,700Daniel E Kaufmann · Massachusetts General Hospital · R01 · FY2011 · HL
Immunoregulatory networks and HIV pathogenesis
$436,700Daniel E Kaufmann · Massachusetts General Hospital · R01 · FY2009 · HL
Canine MHC-I genotyping and tumor specific neoantigen determination
$436,631Shaying Zhao · University Of Georgia · R01 · FY2024 · CA
B-CLL Biology: Impact of Combination Therapy
$436,610Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2003 · CA
NIH Myeloid Malignancy Program
$436,549Steven Pavletic · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Regulation of T cell responses through Zap70 and TCR interaction dynamics.
$436,500Bjoern F Lillemeier · Salk Institute For Biological Studies · R01 · FY2019 · GM
Regulation of T cell responses through Zap70 and TCR interaction dynamics.
$436,500Bjoern F Lillemeier · Salk Institute For Biological Studies · R01 · FY2018 · GM
Regulation of T cell responses through Zap70 and TCR interaction dynamics.
$436,500Bjoern F Lillemeier · Salk Institute For Biological Studies · R01 · FY2020 · GM
Project 2 - Genomics of Allogeneic Transplantation.
$436,495John F Dipersio · Washington University · P01 · FY2022 · CA
Brain Tumor Immunotherapy
$436,461Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Rare Central Nervous System Cancers Initiative
$436,461Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
T memory stem cells in cancer
$436,428Yiping Yang · Duke University · R01 · FY2017 · CA
Multiplexed time domain fluorescence tomography of tumor biomarkers during immunotherapy
$436,422Anand T.n. Kumar · Massachusetts Eye And Ear Infirmary · R01 · FY2024 · CA
CLINICAL TRIALS OF ALLOGENEIC STEM CELL TRANSPLANT IN LYMPHOHEMATOPOIETIC DISORDE
$436,407Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2009 · CA
A Human Antibody as an Immunotherapy for Cocaine Abuse
$436,401Phase 2 Discovery, Inc. · R44 · FY2005 · DA
Project 3: Identifying Targetable Epigenetic and Immuno-Oncologic Vulnerabilities in Synovial Sarcoma
$436,396Marc Ladanyi · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA
The role of the RNA demethylase FTO in metabolic reprogramming of renal cell carcinoma
$436,355Erinn B Rankin · Stanford University · R01 · FY2024 · CA
Targeting Polo-Like Kinase 1 in Prostate Cancer to Enhance Therapeutic Efficacy
$436,322Zhiguo Li · University Of Kentucky · R01 · FY2023 · CA
Activation, Phenotype and Function of CD4 T Cells in Schistosoma-Pulmonary Hypertension
$436,296Brian Barkley Graham · University Of Colorado Denver · R01 · FY2018 · HL
Safer lung cancer radiotherapy delivery using novel artificial intelligence methods
$436,259Harini Veeraraghavan · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Project 2 - Genomics of Allogeneic Transplantation.
$436,241John F Dipersio · Washington University · P01 · FY2023 · CA